Medscape

Medscape is an online platform designed for doctors and healthcare experts. It offers original medical journal articles that have been peer-reviewed, Continuing Medical Education (CME) resources, and a tailored version of the National Library of Medicine's MEDLINE database. Users can also access daily updates on medical news, extensive coverage of significant conferences, and detailed drug information, which includes the Medscape Drug Reference (MDR) and a tool for checking drug interactions. While all content on Medscape is free for both professionals and the public, users must register to access it.

National, Trade/B2B

Dutch, English, French, German, Portuguese, Spanish

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#6690

United States

#3068

Health/Medicine

#21

Traffic sources

Monthly visitors

Articles

Once-Monthly MariTide Promising in Phase 2 Despite GI Issues

2 days ago | medscape.com | Alicia Ault

CHICAGO — Patients with obesity with or without diabetes lost as much as 20% of body weight and showed reductions in A1c levels, after 1 year of treatment with the novel agent maridebart cafraglutide (MariTide), according to the results of a Phase 2 study. However, virtually all patients experienced a gastrointestinal (GI) adverse event, leading as many as 27% to discontinue. Study authors, led by Ania M.
Mifepristone Improves A1C in T2D With Hypercortisolism

2 days ago | medscape.com | Alicia Ault

CHICAGO — Mifepristone treatment improved glycemic control and led to weight loss and a reduction of waist circumference in patients with poorly controlled type 2 diabetes (T2D) and hypercortisolism, according to new data from the CATALYST trial. Results from the prevalence phase of the study, presented last year, indicated that 24% (253) of the 1055 patients enrolled had hypercortisolism, as determined by dexamethasone suppression test.
Semaglutide Shows Benefits for PAD Across T2D Subgroups

3 days ago | medscape.com | Alicia Ault

CHICAGO — Use of the GLP-1 receptor agonist semaglutide improved walking capability in patients with peripheral arterial disease (PAD) and type 2 diabetes (T2D), regardless of duration of diabetes, BMI, or glycemic control, a post-hoc analysis of phase 3 double-blind randomized STRIDE showed. “PAD remains a recalcitrant problem in people living with diabetes.
Training Reduces Clinicians’ Obesity Bias, Improves Practice

4 days ago | medscape.com | Diana Swift

Many healthcare providers (HCPs) harbor bias against people with excess weight or obesity, and that stigmatization can negatively affect patient care. Now, an innovative two-endpoint continuing medical education (CME) initiative has shown that clinicians can change when brought face to face with their negative attitudes and less than optimal referral behaviors regarding patients with obesity.
Docs Urged to Use Genome Tests to Diagnose Kids Early

4 days ago | medscape.com | Lara Salahi

Clinicians should prioritize genetic testing for young children who show signs of intellectual disability (ID) or developmental delays, according to a new report from the American Academy of Pediatrics (AAP), a move intended to improve care and outcomes for families. The clinical report, published in Pediatrics, recommends genome or exome sequencing be used as first-line diagnostic tests in most cases.
Significant Weight Loss With CagriSema, But Less Than Hoped

4 days ago | medscape.com | Alicia Ault

CHICAGO — CagriSema, a new weekly injection from Novo Nordisk combining the amylin analogue cagrilintide with the GLP-1 receptor agonist semaglutide, significantly reduced weight and improved glycemic control and cardiometabolic measures in individuals with overweight/obesity and both overweight/obesity and type 2 diabetes, new research showed.
Avoiding the COVID Shot Talk? Here’s What to Do

5 days ago | medscape.com | Lisa O’Mary

Do you hesitate to bring up COVID vaccines with your patients? You’re not alone — and experts said these conversations are becoming less common in routine care.
Population-Level Weight Loss Seen With Primary Care Protocol

6 days ago | medscape.com | Alicia Ault

CHICAGO — Encouraging patients to talk with their primary care physicians about weight management led to increased visits for obesity, population-wide weight loss, and increased revenue, researchers at the University of Colorado Anschutz School of Medicine (CU Anschutz) reported here at the American Diabetes Association (ADA) 85th Scientific Sessions. The researchers presented data from a 4-year study of the PATHWEIGH protocol, which was implemented at 56 primary care clinics across Colorado.
Clinicians Urge Symptom Awareness, Pre-Screening for Measles

1 week ago | medscape.com | Paul A. Offit |Margot Savoy |Robert M. Jacobson

SummaryDr Savoy outlines the clinical presentation of measles and key signs to watch for during evaluation. Measles is an upper respiratory infection with cold or influenza symptoms and a high fever. Within 6 days, a maculopapular rash, sandpaper-like on a reddish base, typically appears, spreading from the head down the body. Koplik spots, small white lesions inside the mouth, are another symptom to recognize.
Oseltamivir Decreases Hospital Mortality Risk of Influenza

1 week ago | medscape.com | Marcia Frellick

Treating patients with severe influenza with oseltamivir in the first 2 days after hospital admission was associated with a lower in-hospital mortality risk, earlier discharge, and lower readmission rate compared with supportive care, new data indicated. The additional evidence supports current guideline recommendations to treat all people hospitalized with influenza with an antiviral agent, regardless of how long they have been ill. The study, led by Anthony D.